SANGAMO THERAPEUTICS, INC (SGMO) › Total AssetsSANGAMO THERAPEUTICS, INC (SGMO) — Total AssetsAnnual figures by fiscal year, from SEC filings.2010: $63.00M2011: $87.34M2012: $82.53M2013: $140.84M2014: $243.21M2015: $217.24M2016: $157.89M2017: $286.74M2018: $590.39M2019: $637.52M2020: $938.55M2021: $721.92M2022: $562.51M2023: $165.32M2024: $101.64M2025: $59.74M$59.74M2010Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$59.74M-41.2%2024$101.64M-38.5%2023$165.32M-70.6%2022$562.51M-22.1%2021$721.92M-23.1%2020$938.55M+47.2%2019$637.52M+8.0%2018$590.39M+105.9%2017$286.74M+81.6%2016$157.89M-27.3%2015$217.24M-10.7%2014$243.21M+72.7%2013$140.84M+70.6%2012$82.53M-5.5%2011$87.34M+38.6%2010$63.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share